project id: TCGA-STAD; case submitter id: TCGA-IN-A6RL; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.52; rna integrity number: 7.2; age at index: 84; days to birth: -30783; days to death: 406; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1928; age at diagnosis: 30783; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 158.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 307; initial weight: 260.0; sample id: 2c2e9712-6ace-48f1-9470-f3ea60df95a5; sample submitter id: TCGA-IN-A6RL-01A; portion id: b3ed43e7-3f55-4f85-a12e-232a6c036a42; portion submitter id: TCGA-IN-A6RL-01A-11; slide id: 616ef818-5401-47f8-8207-0d296849c3af; slide submitter id: TCGA-IN-A6RL-01A-01-TSA; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 0.0; percent tumor cells: 70.0; percent tumor nuclei: 65.0; section location: TOP;